Binata Shrestha advances diagnostics research with 2026 publications and ADLM presentation

Clinical chemistry scientist Binata Shrestha published multiple peer-reviewed studies in 2026 and presented new research at the Association for Diagnostics and Laboratory Medicine annual meeting. Her work focuses on LC-MS/MS testing, toxicology, and hormone profiling aimed at improving laboratory accuracy and patient care.

Why it matters: - Binata Shrestha’s work centers on improving clinical diagnostic accuracy, especially in toxicology and hormone testing. - The research has practical implications for neonatal care, maternal and infant health, and prenatal drug exposure screening. - Her ADLM presentation puts her methods in front of laboratory medicine peers who influence testing standards and adoption.

What happened: - Binata Shrestha, a clinical chemistry scientist and clinical laboratory professional, published multiple peer-reviewed studies in 2026. - Shrestha submitted an abstract to the 2026 annual meeting of the Association for Diagnostics and Laboratory Medicine (ADLM). - Shrestha presented research on hormone measurements and synthetic urine detection in toxicology testing.

The details: - Shrestha’s research uses liquid chromatography and tandem mass spectrometry, including LC-MS/MS-based methods. - Her recent studies address neonatal opioid withdrawal syndrome detection. - Her published work includes LC-MS/MS-based steroid profiling for maternal and infant health. - Shrestha also completed a systematic review of LC-MS/MS panels for detecting prenatal drug exposure in meconium samples. - Her research aims to improve hormone profiling and drug screening. - Shrestha is currently a clinical chemistry scientist at Gnosis, including MVML and TruArc Health. - Her responsibilities include complex toxicological and molecular testing, as well as test development and validation support. - Shrestha has also worked at Patient Choice Laboratories and Quest Diagnostics. - Her experience there included blood chemistry analysis, toxicological testing, and instrument maintenance. - Shrestha has worked in hospitals and clinical laboratories across the United States and Nepal. - Her background includes Dean’s List honors, merit-based awards, specialized laboratory training, Siemens Atellica Solution key operator training, and healthcare research practice. - Shrestha holds a master’s degree in biomedical sciences from Troy University. - Shrestha earned a bachelor’s degree in medical biochemistry from Pokhara University. - Shrestha is certified by the American Society for Clinical Pathology (ASCP).

Between the lines: - Shrestha’s mix of research, laboratory operations, and validation work points to a career built around translating advanced methods into routine clinical use. - The focus on LC-MS/MS suggests an emphasis on highly sensitive testing that can improve detection and reduce ambiguity in clinical results. - Her presentation at ADLM signals peer-level recognition in a field where method quality and reproducibility matter.

What's next: - Shrestha is positioned to continue developing and presenting laboratory methods tied to toxicology, steroid profiling, and hormone measurement. - Her current work in test development and validation suggests more applied research may follow in clinical settings. - Additional publication and conference activity could further expand the reach of her diagnostic approaches.